Bausch + Lomb reports positive 24-month trial data for glaucoma treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Bausch + Lomb reports positive 24-month trial data for glaucoma treatment
(NYSE: BLCO) Delayed: 15.08 -0.21 (1.37%)
Previous Close $15.29    52 Week High $ 
Open $15.40    52 Week Low $ 
Day High $15.44    P/E N/A 
Day Low $15.04    EPS $ 
Volume 276,317